Lipid peroxidation and platelet activation in murine atherosclerosis

Circulation

Volumn 104, Issue 16, 2001, Pages 1940-1945

  Cyrus, Tillmann ^a   Tang, Lina X ^a   Rokach, Joshua ^b   FitzGerald, Garret A ^a   Praticò, Domenico ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Florida Institute of Technology   (United States)

Author keywords

Antioxidants; Atherosclerosis; Free radicals; Inflammation; Thromboxane

Indexed keywords

2,3 DINORTHROMBOXANE B2; ALPHA TOCOPHEROL; ANTIOXIDANT; FREE RADICAL; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; ISOPROSTANE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; LIPID DIET; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; URINE LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0035899906     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4101.097114     Document Type: Article

References (33)

1. Oxidative modification of LDL and atherogenesis
2. Lipoprotein, lipoprotein oxidation and atherosclerosis
3. Oxidized phospholipids and isoprostanes in atherosclerosis
4. Effect of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice
5. Antiatherogenic effects of the antioxidant BO-653 in three different animal models
6. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
7. Aspirin as antiplatelet drug
8. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
9. Antiplatelet therapy for thromboprophylaxis: The need for careful consideration of the evidence from randomized trials
10. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial
11. 2-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo
12. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis
13. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in LDL receptor knock-out mice
14. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation
15. Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator
16. 2α generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo
17. Biochemical evidence of a chronic abnormality in platelet and vascular function in apparently healthy chronic cigarette smokers
18. Modulation of oxidant stress in vivo in chronic cigarette smokers
19. 2-isoprostanes in human atherosclerotic lesions
20. 2α is increased in hypercholesterolemia
21. 2-isoprostanes in hypercholesterolemia
22. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice
23. 2-isoprostanes by HPLC/tandem mass spectrometry
24. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other nonsteroidal anti-inflammatory drugs
25. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
26. Atherosclerosis: An inflammatory disease
27. Chemokines and atherosclerosis
28. Nitric oxide regulates cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells
29. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-α-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells
30. 2 and other eicosanoids
31. The TP-receptor antagonist, S18886, but not aspirin, inhibits atherogenesis in apolipoprotein E deficient mice: Evidence that other eicosanoids contribute to atherogenesis
32. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo
33. 2 receptor in vivo